Middle East & Africa Lithotripsy Market

The Middle East & Africa lithotripsy market was valued at US$ 57.68 million in 2023 and is expected to reach US$ 82.58 million by 2031; it is estimated to register a CAGR of 4.6% from 2023 to 2031.

Preference for Lithotripsy Technique in Coronary Lesion Treatment Bolsters Middle East & Africa Lithotripsy Market

Traditionally, lithotripsy is the most recommended noninvasive procedure for kidney stone removal. However, manufacturers are studying lithotripsy medical devices that can be utilized for several other healthcare applications, including the treatment of coronary lesions. With the rise in the aging population, there is a high risk of patients suffering from coronary lesions. Currently, several challenges are associated with coronary intervention, including dissections/incisions. Also, only a few methods are available to manage calcified coronary lesions, including interventional balloons and rotational atherectomy. Furthermore, incisions and incorporating balloons do not remove calcium deposits as they only improve vessel compliance by creating incisions. Such uncontrolled incisions can lead to a high risk of vessel perforation and increased chances of myocardial infarction among patients undergoing cardiac surgery. The new technology of shockwave lithotripsy is set to revolutionize disease treatment through the proper management of severely calcified coronary lesions. In February 2021, the FDA announced approval for a shockwave intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary artery plaques. For example, Shockwave Medical Inc.'s SHOCKWAVE IVL removes coronary lesions by reducing the risk of complications and making the procedure safe and efficient. Thus, preference for the lithotripsy technique in coronary lesion treatment is anticipated to fuel the Middle East and Africa lithotripsy market growth in the coming years.

Middle East & Africa Lithotripsy Market Overview

According to the Scienceopen Journal, epidemiologically, Saudi Arabia has a higher incidence rate of urolithiasis in the Middle East & Africa, i.e., about 6.8-19.1%. Also, the population is estimated to have a 2.5 times higher possibility of developing urolithiasis in Saudi Arabia in the coming years. Further, the introduction of shockwave lithotripsy (SWL) has revolutionized urolithiasis treatment in Saudi Arabia. To minimize the prevalence rate of urolithiasis among the population, advancements in technological devices are highly required, which will result in low urolithiasis morbidity cases and short hospitalization periods.

Middle East & Africa Lithotripsy Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Lithotripsy Strategic Insights

Strategic insights for the Middle East & Africa Lithotripsy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Lithotripsy Report Scope

Middle East & Africa Lithotripsy Regional Insights

The geographic scope of the Middle East & Africa Lithotripsy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Lithotripsy Market Segmentation

The Middle East & Africa lithotripsy market is categorized into product type, application, end user, and country.

By product type, the Middle East & Africa lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices, intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the Middle East & Africa lithotripsy market share in 2023.

In term of application, the Middle East & Africa lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the Middle East & Africa lithotripsy market share in 2023.

Based on end user, the Middle East & Africa lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the Middle East & Africa lithotripsy market share in 2023.

Based on country, the Middle East & Africa lithotripsy market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia segment held the largest share of Middle East & Africa lithotripsy market in 2023.

Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the Middle East & Africa lithotripsy market.